Our customers' Feedback
Search:
Perform search
Categories list

Generic Ezetimibe - Vytorin, Zetia

News
Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Vytorin
Generic Vytorin is used for treating high cholesterol along with a cholesterol-lowering diet. It works by reducing the amount of cholesterol that your body absorbs from your meals. Lowering cholesterol levels in the blood reduces the chance of heart disease, heart attacks and strokes.
$1.97
Zetia
Generic Zetia is used for treating high blood cholesterol along with a low-fat, low-cholesterol diet. It may be used alone or with other medicines. It is also used to treat high blood sitosterol and campesterol along with diet therapy.
$1.17
Social bookmarks:
Choose your language:



Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • Merck Wins U.S. ZETIA(R) (ezetimibe)/ VYTORIN(R) (ezetimibe/simvastatin ... - MarketWatch (press release)

    Merck Wins U.

  • Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks; - FiercePharma

    Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks;FiercePharmaArticle | Follow @FiercePharma > A US court upheld Merck's ($MRK) patent on the active ingredient ezetimibe, marketed as the cholesterol-lowering Zetia and in the combo cholesterol pill Vytorin.

  • Investor Medical Waves - (VVUS, MRK, MYL, AMPE) - Galaxy Stocks

    Investor Medical Waves - (VVUS, MRK, MYL, AMPE)Galaxy StocksInc.

  • Advanced Atherosclerosis: The Heart and Beyond - Medscape

    Advanced Atherosclerosis: The Heart and BeyondMedscapeThe premise of AIM-HIGH was to see if adding extended-release niacin to raise HDL cholesterol in patients who had already achieved a very low LDL cholesterol level (40 to 80 mg/dL) with simvastatin (and ezetimibe if needed) would lead to further risk .

  • Toward Regenerative Medicine Against Atherosclerosis cardiovascular disease - Next Big Future

    Toward Regenerative Medicine Against Atherosclerosis cardiovascular diseaseNext Big FutureOnce-promizing agents such as ezetimibe, niacin, ApoA-1 Milano, and torcetrapib have either been found to provide no benefit, or evento increase mortality rates.

    Copyright © 2007-2011 Online Canadian Pharmacy is an affiliate marketing website. All rights reserved.